Updated guidance on the management of children with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID)

Pulmonary Fibrosis

Impact of a cystic fibrosis transmembrane conductance regulator (CFTR) modulator on high-dose ibuprofen therapy in pediatric cystic fibrosis patients

Pediatr Pulmonol.

Bruch BA, Singh SB, Ramsey LJ, Starner TD

doi: 10.1002/ppul.24024.

Pulmonary Fibrosis

Cystic fibrosis screen positive inconclusive diagnosis (CFSPID): Experience in Tuscany, Italy

J Cyst Fibros.

Terlizzi V, Mergni G, Buzzetti R, Centrone C, Zavataro L, Braggion C

doi: 10.1016/j.jcf.2019.04.002.

Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation

J Pediatr.

Farrell PM, White TB, Ren CL, Hempstead SE, Accurso F, Derichs N, Howenstine M, McColley SA, Rock M, Rosenfeld M, Sermet-Gaudelus I, Southern KW, Marshall BC, Sosnay PR

doi: 10.1016/j.jpeds.2016.09.064.

RECOMMENDED

AsthmaPulmonary Fibrosis

New treatments in respiratory medicine in 2018 : asthma, cystic fibrosis and nocturnal positive pressure (CPAP or NIV)

Rev Med Suisse.

Plojoux J, Charbonnier F, Janssens JP

RECOMMENDED

Pulmonary Fibrosis

Health-related quality-of-life in children with cystic fibrosis aged 5-years and associations with health outcomes

★ 1 Recommended by Dr Martin Frey, Faculty Member

J Cyst Fibros.

Cheney J, Vidmar S, Gailer N, Wainwright C, Douglas TA, Australasian Cystic Fibrosis Bronchoalveolar Lavage (ACFBAL) study group.

doi: 10.1016/j.jcf.2020.02.022.

Diagnosis and management of asthma - Statement on the 2015 GINA Guidelines

Horak F, Doberer D, Eber E, Horak E, Pohl W, Riedler J, Szépfalusi Z, Wantke F, Zacharasiewicz A, Studnicka M

Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study

Lancet Respir Med.

Rosenfeld M, Wainwright CE, Higgins M, Wang LT, McKee C, Campbell D, Tian S, Schneider J, Cunningham S, Davies JC; ARRIVAL study group

doi: 10.1016/S2213-

Pulmonary Fibrosis

Bone mineral density is related to lung function outcomes in young people with cystic fibrosis-A retrospective study

Pediatr Pulmonol.

Smith N, Lim A, Yap M, King L, James S, Jones A, Ranganathan S, Simm P

doi: 10.1002/ppul.23894.

CoughPulmonary Fibrosis

The CF-Sputum Induction Trial (CF-SpIT) to assess lower airway bacterial sampling in young children with cystic fibrosis: a prospective internally controlled interventional trial

Ronchetti K, Tame JD, Paisey C, Thia LP, Doull I, Howe R, Mahenthiralingam E, Forton JT

doi: 10.1016/

Related content

Impact of a cystic fibrosis transmembrane conductance regulator (CFTR) modulator on high-dose ibuprofen therapy in pediatric cystic fibrosis patients

Cystic fibrosis screen positive inconclusive diagnosis (CFSPID): Experience in Tuscany, Italy

Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation

New treatments in respiratory medicine in 2018 : asthma, cystic fibrosis and nocturnal positive pressure (CPAP or NIV)

Health-related quality-of-life in children with cystic fibrosis aged 5-years and associations with health outcomes

Diagnosis and management of asthma - Statement on the 2015 GINA Guidelines

Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study

Bone mineral density is related to lung function outcomes in young people with cystic fibrosis-A retrospective study

The CF-Sputum Induction Trial (CF-SpIT) to assess lower airway bacterial sampling in young children with cystic fibrosis: a prospective internally controlled interventional trial